Blockchain is a revolutionary solution to data concerns in a clinical trial setting, Innoplexus Founder and CEO Gunjan Bhardwaj writes in an article published on pharmaphorum.
” … Today’s researchers researchers face the challenges of accurately reproducing data, efficiently sharing data (including personal data), privacy concerns and patient enrollment strategies,” he writes.
Bhardwaj says the “best part” about blockchain is its resistance to hacking, theft and infringement due to the technology’s data storage foundation.
” … The ledger is not kept on a single repository, but is spread through multiple databases in replicate copies,” Bhardwaj writes. “These verification requirements ensure that stored data remains intact and immutable.”
To read Bhardwaj’s full write up on pharmaphorum, click here.